Our vision: individualize cancer medicine
IR Side Nav
Investor Contact Sylke Maas, Ph.D.
VP Investor Relations & Business Strategy
Send Email
+49 6131 9084-0
VP Investor Relations & Business Strategy
Send Email
+49 6131 9084-0
Media Contact Jasmina Alatovic
Director Global External Communications
Send Email
+49 6131 9084-0
Director Global External Communications
Send Email
+49 6131 9084-0
SEC Filings
Filing date | Description | Form | View |
---|---|---|---|
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
Securities offered to employees pursuant to employee benefit plans |
S-8 | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
An amendment to the SC 13G filing |
SC 13G/A | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML |
Displaying 1 - 10 of 142 results
Data provided by Kaleidoscope.